The structural–activity relationship (SAR) describes the link between a molecule's chemical structure and its biological activity. The determination of the chemical group responsible for triggering a target biological action in the organism is possible via SAR analysis. This allows for the change of a bioactive compound's action or potency (usually a medication) by altering its chemical structure. Medicinal chemists employ chemical synthesis techniques to introduce new chemical groups into medicinal compounds and then test their biological effects. The Structure-Activity Relationship (SAR) method is used to discover correlations between a compound's chemical structure (or structural-related attributes) and its biological activity (or target property). As such, it is the idea of connecting chemical structure to a chemical characteristic (e.g., water solubility) or biological activity (e.g., toxicity) (e.g., fish acute mortality). (Q)SARs are a term that refers to both qualitative and quantitative SARs. Non-continuous data (e.g., yes/no data) yields qualitative relationships, whereas continuous data yields quantitative correlations (e.g., toxic potency data).
Title : A qsar survey on tyrosine kinase inhibitors
Atefeh Hajiagha Bozorgi, Faculty of pharmacy, Iran (Islamic Republic of)
Title : Abbott diagnostics: COVID-19 inactivation, nucleocapsid antigen automated immunoassay development, and variant testing for automated and lateral flow assays binaxnow™ and panbio™
Philip M Hemken, Abbott Laboratories, United States
Title : Synthesis, antibacterial activity of 3-amino 5-methoxyl-2-methyl quinazolin-4(3H)-one an amino-6-methoxyl-2-methyl of 4H–benzo[d] [1,3]–oxazine–4–one
Osarumwense Peter Osarodion, Ondo State University of Sciences and Technology, Nigeria
Title : Tackling mycobacterium tuberculosis resistance with tailored isatin-pyrimidine hybrids enoyl acyl carrier protein reductase (Inha)
Amgad Albohy, The British University in Egypt (BUE), Egypt
Title : Transition metal complexes/Organometallic compounfs as anticancer drugs
Prakash kinthda, Nims university,jaipur,rajasthan, India
Title : New n-ribosides and n-mannosides of rhodanine derivatives with anticancer activity on leukaemia cell line: Design, synthesis, dft and molecular modelling studies
Ahmed, Kafrelsheikh University, Egypt